These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 387151)

  • 1. High dose flupenthixol decanoate in chronic schizophrenia.
    McCreadie RG; Flanagan WL; McKnight J; Jorgensen A
    Br J Psychiatry; 1979 Aug; 135():175-9. PubMed ID: 387151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Pinto R; Bannerjee A; Ghosh N
    Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia.
    Johnson DA; Ludlow JM; Street K; Taylor RD
    Br J Psychiatry; 1987 Nov; 151():634-8. PubMed ID: 3446307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
    Wistedt B; Ranta J
    Acta Psychiatr Scand; 1983 Jun; 67(6):378-88. PubMed ID: 6349256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison.
    Eberhard G; Hellbom E
    Acta Psychiatr Scand; 1986 Sep; 74(3):255-62. PubMed ID: 3788652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B
    Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
    Eufe R; Wegener G
    Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime.
    Cookson IB
    Int Clin Psychopharmacol; 1987 Apr; 2(2):141-9. PubMed ID: 3298419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
    Dencker SJ; Lepp M; Malm U
    Acta Psychiatr Scand Suppl; 1980; 279():10-28. PubMed ID: 6931470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flupenthixol decanoate - controlled investigation concerning dosage -.
    Agrup-Andersson L; Bengtsson A; Erlandsson K; Gottfries CG; Witzell-Ostlund G
    Acta Psychiatr Scand Suppl; 1974; 255():7-14. PubMed ID: 4618720
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dose and serum drug level and its clinical effects during the long-term treatment of chronic schizophrenia with flupenthixol depot].
    Lipska B; Szukalski B; Nurowska K; Welbel L
    Psychiatr Pol; 1986; 20(1):1-7. PubMed ID: 3725983
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioreceptor assay in checking serum concentration in long-term treatment with cis(z)-flupenthixol decanoate.
    Lipska B; Welbel L; Nurowska K; Szukalski B
    Act Nerv Super (Praha); 1987 Dec; 29(4):270-3. PubMed ID: 3439426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia.
    Johnson DA; Malik NA
    Acta Psychiatr Scand; 1975 May; 51(4):257-67. PubMed ID: 1096536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroral and parenteral administration of long-acting neuroleptics: a double-blind study of penfluridol compared to flupenthixol decanoate in the treatment of schizophrenia.
    Gerlach J; Kramp P; Kristjansen P; Lauritsen B; Lühdorf K; Munkvad I
    Acta Psychiatr Scand; 1975 Aug; 52(2):132-44. PubMed ID: 1096541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.
    Wistedt B; Jørgensen A; Wiles D
    Psychopharmacology (Berl); 1982; 78(4):301-4. PubMed ID: 6818587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
    Ehmann TS; Delva NJ; Beninger RJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state serum concentrations after cis (Z)-flupentixol decanoate in viscoleo.
    Saikia JK; Jørgensen A
    Psychopharmacology (Berl); 1983; 80(4):371-3. PubMed ID: 6414008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
    Carney MW; Sheffield BF
    Br J Psychiatry; 1976 Nov; 129():476-81. PubMed ID: 990663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial of flupenthixol decanoate in chronic withdrawn schizophrenic patients.
    Vichaiya V
    J Med Assoc Thai; 1980 Apr; 63(4):205-9. PubMed ID: 6991627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.